A Randomized Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects with Disability Following an Ischemic Stroke

A Randomized Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects with Disability Following an Ischemic Stroke
Recruiting
18 years - 99 years
All
Phase 2
6 participants needed
1 Location

Brief description of study

The research study is being conducted to find out if this study drug provides any improvement in the arm and/or leg function affected by the stroke. The study will also gather more information about the safety of the study drug, surgical procedure and equipment used to inject the study drug. The study drug is called CTX0E03 DP and is made from stem cells. The study drug, including the equipment being used to give the stem cells, is experimental and will be injected into the brain

Detailed description of study

If you agree to join the study, following confirmation of eligibility criteria, you will be randomized in 2:1 ratio to receive either a single administration of CTX0E03 DP by intracerebral implantation or receive placebo surgery only. Subjects will be followed for 12 months after study drug administration or placebo surgery with follow-up assessments occurring at Day 1, 7, and Months 1, 3, 6, 9, and 12. All eligible subjects will be assigned a standardized PT program based on their baseline functional impairment. Subjects will be expected to complete their PT exercises daily, and independently or with a family member/caregiver for 12 wks post-surgery.
Your participation will last for will last approximately 1 year. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Stroke
  • Age: 18 years - 99 years
  • Gender: All


Updated on 19 Feb 2024. Study ID: 832621

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.